Consultants


Mr Nicholas Kalaverezos
| Qualifications |
|
| Year Qualified |
|
| Languages |
|
| Consulting address |
|
| Sub Speciality |
Head & Neck Surgery |
| NHS base |
|
Biography
Nicholas Kalavrezos is a Consultant in Oral and Maxillofacial Surgery at University College London Hospitals with a sub-specialty interest in oral oncology and microvascular reconstruction. His clinical practice also includes surgical treatment of salivary gland neoplasms, as well as thyroid surgery.
Nicholas was born in October 1962 in Athens, Greece to a medical family. His father was an obstetrician – gynaecologist in Athens – and Nicholas was brought up visiting his father's medical practice regularly. This influenced him significantly in choosing a surgical career from a very early stage of his life.
Nicholas started his undergraduate training in dentistry in 1980 at the University of Athens. Given his desire to follow a surgical career he continued to study medicine at the University of Patras where he graduated in 1992. During his medical training Nicholas spent his summer holidays visiting eminent Maxillofacial Units in Europe. One of these observerships included time spent with Professor Hermann Sailer, Professor of Maxillofacial Surgery at the University Hospital of Zurich in Switzerland. Professor Sailer was impressed by Nicholas’s enthusiasm and, indeed, offered him a full resident post in his unit.
He started his maxillofacial career in the University Hospital in Zurich in 1993 following one year’s training in general surgery. In Zurich he completed his thesis in the management of craniofacial trauma. After a four-year residential programme, he moved to the UK where he completed his training. The emphasis was on head and neck oncology and microvascular surgery and therefore Nicholas gained experience in eminent UK centres such as Liverpool, Mount Vernon, St Bartholomew’s and the Royal London Hospital.
In early 2002 he was appointed Consultant Maxillofacial Surgeon at University College London Hospitals with a sub-specialty interest in oral oncology and microvascular reconstruction. Within the last 5 years the Head and Neck Unit at the University College Hospital has been developed into one of the busiest and most successful Head and Neck Units in the country. The surgical armamentarium of the Centre has improved vastly- Nicholas carries out one to two microvascular cases per week with success rates well beyond 95%! His clinical practice also includes surgical treatment of salivary gland neoplasms as well as thyroid surgery.
He has set up links with various centres in Europe and he organizes annual conferences of head & neck oncology and facial reconstruction.
Of particular interest are the links he developed with patients from Nigeria - coming to London for unique single stage treatment of huge, face disfiguring tumours such as ameloblastomas.
These patients have been refused treatment elsewhere and indeed, they come to London for life-changing, single-stage surgical treatment:
